Replacing   agonists with antimuscarinic drugs in patients with COPD

Replacing   agonists with antimuscarinic drugs in patients with COPD

The paper by Quint and colleagues and its linked editorial show the benefits of [beta] blockers on mortality in patients with the common combination of myocardial infarction and chronic obstructive pulmonary disease. 1 2 The competitive blockade of [beta] adrenoceptors by [beta] blockers surely nega...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BMJ (Online) 2014-01, Vol.348 (jan29 1), p.g1108-g1108
1. Verfasser: Wolstenholme, Roger J
Format: Artikel
Sprache:eng
Schlagworte:
Beta
Chronic obstructive pulmonary disease
Health risk assessment
Heart attacks
Mortality
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page g1108
container_issue jan29 1
container_start_page g1108
container_title BMJ (Online)
container_volume 348
creator Wolstenholme, Roger J
description The paper by Quint and colleagues and its linked editorial show the benefits of [beta] blockers on mortality in patients with the common combination of myocardial infarction and chronic obstructive pulmonary disease. 1 2 The competitive blockade of [beta] adrenoceptors by [beta] blockers surely negates the beneficial effects of [beta] agonists, such as salbutamol and salmeterol. Effect of [beta] blockers on mortality after myocardial infarction in adults with COPD: population based cohort study of UK electronic healthcare records.
doi_str_mv 10.1136/bmj.g1108
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1930582035</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1930582035</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1305-5492d0bb752e5d406d47f6672eec3f9ffd809cdad77d2e80fc9ffcb0ce99bdc23</originalsourceid><addsrcrecordid>eNp9kMtKAzEYhYMoWGoXvkHAlYupuUwmyVJqvUChIroOmVzGlDYzJjOIb-Oz-GSOVsGVq_Nz-PgPfACcYjTHmFYX9W4zbzBG4gBMMGdVgQWlh3_uYzDLeYMQIpQLWbEJWD64bqtNiA38eIe6aWPIfYavoX-GOvZhN2SjU4jBQJuGJsMQYaf74OIvtVjfX52AI6-32c1-cgqerpePi9titb65W1yuCoMpYgUrJbGorjkjjtkSVbbkvqo4cc5QL723AkljteXcEieQN2NnamSclLU1hE7B2f5vl9qXweVebdohxXFSYTkuCIIo-5cSjFIpqSxH6nxPmdTmnJxXXQo7nd4URupLpxp1qm-d9BNo5GgW</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1853399394</pqid></control><display><type>article</type><title>Replacing   agonists with antimuscarinic drugs in patients with COPD</title><source>BMJ Journals - NESLi2</source><source>JSTOR Archive Collection A-Z Listing</source><creator>Wolstenholme, Roger J</creator><creatorcontrib>Wolstenholme, Roger J</creatorcontrib><description>The paper by Quint and colleagues and its linked editorial show the benefits of [beta] blockers on mortality in patients with the common combination of myocardial infarction and chronic obstructive pulmonary disease. 1 2 The competitive blockade of [beta] adrenoceptors by [beta] blockers surely negates the beneficial effects of [beta] agonists, such as salbutamol and salmeterol. Effect of [beta] blockers on mortality after myocardial infarction in adults with COPD: population based cohort study of UK electronic healthcare records.</description><identifier>ISSN: 1756-1833</identifier><identifier>EISSN: 1756-1833</identifier><identifier>DOI: 10.1136/bmj.g1108</identifier><language>eng</language><publisher>London: BMJ Publishing Group LTD</publisher><subject>Beta ; Chronic obstructive pulmonary disease ; Health risk assessment ; Heart attacks ; Mortality</subject><ispartof>BMJ (Online), 2014-01, Vol.348 (jan29 1), p.g1108-g1108</ispartof><rights>Copyright: 2014 (c) BMJ Publishing Group Ltd 2014</rights><rights>Copyright: 2014 © BMJ Publishing Group Ltd 2014</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1305-5492d0bb752e5d406d47f6672eec3f9ffd809cdad77d2e80fc9ffcb0ce99bdc23</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,3194,27923,27924</link.rule.ids></links><search><creatorcontrib>Wolstenholme, Roger J</creatorcontrib><title>Replacing   agonists with antimuscarinic drugs in patients with COPD</title><title>BMJ (Online)</title><description>The paper by Quint and colleagues and its linked editorial show the benefits of [beta] blockers on mortality in patients with the common combination of myocardial infarction and chronic obstructive pulmonary disease. 1 2 The competitive blockade of [beta] adrenoceptors by [beta] blockers surely negates the beneficial effects of [beta] agonists, such as salbutamol and salmeterol. Effect of [beta] blockers on mortality after myocardial infarction in adults with COPD: population based cohort study of UK electronic healthcare records.</description><subject>Beta</subject><subject>Chronic obstructive pulmonary disease</subject><subject>Health risk assessment</subject><subject>Heart attacks</subject><subject>Mortality</subject><issn>1756-1833</issn><issn>1756-1833</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp9kMtKAzEYhYMoWGoXvkHAlYupuUwmyVJqvUChIroOmVzGlDYzJjOIb-Oz-GSOVsGVq_Nz-PgPfACcYjTHmFYX9W4zbzBG4gBMMGdVgQWlh3_uYzDLeYMQIpQLWbEJWD64bqtNiA38eIe6aWPIfYavoX-GOvZhN2SjU4jBQJuGJsMQYaf74OIvtVjfX52AI6-32c1-cgqerpePi9titb65W1yuCoMpYgUrJbGorjkjjtkSVbbkvqo4cc5QL723AkljteXcEieQN2NnamSclLU1hE7B2f5vl9qXweVebdohxXFSYTkuCIIo-5cSjFIpqSxH6nxPmdTmnJxXXQo7nd4URupLpxp1qm-d9BNo5GgW</recordid><startdate>20140129</startdate><enddate>20140129</enddate><creator>Wolstenholme, Roger J</creator><general>BMJ Publishing Group LTD</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88I</scope><scope>8AF</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ASE</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FPQ</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K6X</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M2O</scope><scope>M2P</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope></search><sort><creationdate>20140129</creationdate><title>Replacing   agonists with antimuscarinic drugs in patients with COPD</title><author>Wolstenholme, Roger J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1305-5492d0bb752e5d406d47f6672eec3f9ffd809cdad77d2e80fc9ffcb0ce99bdc23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Beta</topic><topic>Chronic obstructive pulmonary disease</topic><topic>Health risk assessment</topic><topic>Heart attacks</topic><topic>Mortality</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wolstenholme, Roger J</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Proquest Nursing &amp; Allied Health Source</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Index</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>British Nursing Index</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><jtitle>BMJ (Online)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wolstenholme, Roger J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Replacing   agonists with antimuscarinic drugs in patients with COPD</atitle><jtitle>BMJ (Online)</jtitle><date>2014-01-29</date><risdate>2014</risdate><volume>348</volume><issue>jan29 1</issue><spage>g1108</spage><epage>g1108</epage><pages>g1108-g1108</pages><issn>1756-1833</issn><eissn>1756-1833</eissn><abstract>The paper by Quint and colleagues and its linked editorial show the benefits of [beta] blockers on mortality in patients with the common combination of myocardial infarction and chronic obstructive pulmonary disease. 1 2 The competitive blockade of [beta] adrenoceptors by [beta] blockers surely negates the beneficial effects of [beta] agonists, such as salbutamol and salmeterol. Effect of [beta] blockers on mortality after myocardial infarction in adults with COPD: population based cohort study of UK electronic healthcare records.</abstract><cop>London</cop><pub>BMJ Publishing Group LTD</pub><doi>10.1136/bmj.g1108</doi></addata></record>
fulltext fulltext
identifier ISSN: 1756-1833
ispartof BMJ (Online), 2014-01, Vol.348 (jan29 1), p.g1108-g1108
issn 1756-1833
1756-1833
language eng
recordid cdi_proquest_journals_1930582035
source BMJ Journals - NESLi2; JSTOR Archive Collection A-Z Listing
subjects Beta
Chronic obstructive pulmonary disease
Health risk assessment
Heart attacks
Mortality
title Replacing   agonists with antimuscarinic drugs in patients with COPD
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T23%3A15%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Replacing%20%C2%A0%20agonists%20with%20antimuscarinic%20drugs%20in%20patients%20with%20COPD&rft.jtitle=BMJ%20(Online)&rft.au=Wolstenholme,%20Roger%20J&rft.date=2014-01-29&rft.volume=348&rft.issue=jan29%201&rft.spage=g1108&rft.epage=g1108&rft.pages=g1108-g1108&rft.issn=1756-1833&rft.eissn=1756-1833&rft_id=info:doi/10.1136/bmj.g1108&rft_dat=%3Cproquest_cross%3E1930582035%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1853399394&rft_id=info:pmid/&rfr_iscdi=true